Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Focus Groups × Tumor-Agnostic × Clear all

Status

Active not recruiting 2 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 4 Thoracic 3 Gynecologic 3 Genitourinary 2 Dermatologic 2 CNS 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Other 1 Head & Neck 1

Conditions

Interventions

Paclitaxel 52 Carboplatin 48 Surveys and Questionnaires 43 Gemcitabine 41 Bevacizumab 35 Docetaxel 30 pembrolizumab 28 Nivolumab 25 Cisplatin 24 Fluorouracil 23 Erlotinib Hydrochloride 21 Capecitabine 21 Irinotecan 20 Sorafenib 19 Leucovorin 18 Pemetrexed 16 Oxaliplatin 16 Afatinib 16 Trastuzumab 15 Radiotherapy 15 regorafenib 14 olaparib 13 Ipilimumab 13 Blood Specimen Collection 13 Sunitinib 12 Interviews as Topic 12 Cetuximab 12 130-nm albumin-bound paclitaxel 12 Standard of Care 11 eribulin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02651831 2024-01-17

FACT-ICM

University Health Network, Toronto

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡